Literature DB >> 8934442

Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.

S Lund-Katz1, Y M Murley, E Yon, K L Gillotte, W S Davidson.   

Abstract

High density lipoprotein (HDL) is thought to play a significant role in the process of reverse cholesterol transport. It has become clear that the apolipoprotein (apo) composition of HDL is important in determining the metabolic fate of this particle. The major proteins of human HDL are apoAI and APOAII; the latter protein is a disulfide-linked dimer in humans and higher primates but monomeric in the other species. The consequences of the apo Cys6-Cys6 disulfide bridge in apoAII for human HDL structure and function are not known. To address this issue, the influence of the Cys6-Cys6 disulfide bridge on the interaction of human apoAII with palmitoyl-oleoyl phosphatidylcholine has been studied. The size and valence of a series of homogeneous discoidal complexes containing either monomeric (reduced and carboxymethylated) or dimeric apoAII have been determined, and their ability to remove cholesterol from rat Fu5AH hepatoma cells grown in culture has been compared. The apoAII dimer and monomer form discoidal complexes of similar size, with twice as many of the latter molecule required per disc. Removal of the disulfide bond influences the stability of the helical segments around the edge of the disc as seen by a decrease in alpha-helix content of the monomeric protein. The discoidal particles containing the monomeric form of apoAII are somewhat more effective than particles containing either dimeric apoAII or apoAI in removing cellular cholesterol. Overall, reduction of the disulfide bridge of apoAII probably does not have a major effect in the determination of HDL particle size in vivo. It follows that the evolution of the Cys6-Cys6 disulfide bond in higher primates probably has not had a major effect on the function of the apoAII molecule.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934442     DOI: 10.1007/bf02524284

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  42 in total

1.  Electron microscopy of negatively stained lipoproteins.

Authors:  T M Forte; R W Nordhausen
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  Interaction of apolipoprotein A-II with recombinant HDL containing egg phosphatidylcholine, unesterified cholesterol and apolipoprotein A-I.

Authors:  K A Rye
Journal:  Biochim Biophys Acta       Date:  1990-02-06

3.  Use of cross-linking reagents to study lipoprotein structure.

Authors:  J B Swaney
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Human high density lipoprotein, apolipoprotein glutamine II. The immunochemical and lipid-binding properties of apolipoprotein glutamine II derivatives.

Authors:  R L Jackson; J D Morrisett; H J Pownall; A M Gotto
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

5.  Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein.

Authors:  H J Pownall; D Hickson; A M Gotto
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

6.  Effects of acceptor particle size on the efflux of cellular free cholesterol.

Authors:  W S Davidson; W V Rodrigueza; S Lund-Katz; W J Johnson; G H Rothblat; M C Phillips
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

7.  Interaction of apolipoprotein AII with the putative high-density lipoprotein receptor.

Authors:  P K Vadiveloo; C M Allan; B J Murray; N H Fidge
Journal:  Biochemistry       Date:  1993-09-14       Impact factor: 3.162

8.  The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol.

Authors:  W S Davidson; K L Gillotte; S Lund-Katz; W J Johnson; G H Rothblat; M C Phillips
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

9.  Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.

Authors:  C C Hedrick; L W Castellani; C H Warden; D L Puppione; A J Lusis
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

10.  Sterol to phospholipid molar ratios of L cells with qualitative and quantitative variations of cellular sterol.

Authors:  L Sokoloff; G H Rothblat
Journal:  Proc Soc Exp Biol Med       Date:  1974-09
View more
  10 in total

1.  Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Authors:  Baiba K Gillard; Hu-Yu Alice Lin; John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2009-07-25

2.  Setting the course for apoAII: a port in sight?

Authors:  Henry J Pownall; Baiba K Gillard; Antonio M Gotto
Journal:  Clin Lipidol       Date:  2013-10

3.  Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

4.  Kinetic stabilization and fusion of apolipoprotein A-2:DMPC disks: comparison with apoA-1 and apoC-1.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

5.  Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases.

Authors:  Shobini Jayaraman; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-18       Impact factor: 5.187

6.  Mass spectral analyses of the two major apolipoproteins of great ape high density lipoproteins.

Authors:  Donald L Puppione; Della Donna Lorenza; Arthur D Laganowsky; Sara Bassilian; Puneet Souda; Oliver A Ryder; Julian P Whitelegge
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2009-12       Impact factor: 2.674

7.  Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.

Authors:  Ida Azizkhanian; Olgica Trenchevska; Yara Bashawri; Jiaqi Hu; Juraj Koska; Peter D Reaven; Randall W Nelson; Dobrin Nedelkov; Hussein N Yassine
Journal:  J Clin Lipidol       Date:  2016-03-08       Impact factor: 4.766

8.  Effect of niacin monotherapy on high density lipoprotein composition and function.

Authors:  Scott M Gordon; Marcelo J Amar; Kianoush Jeiran; Michael Stagliano; Emma Staller; Martin P Playford; Nehal N Mehta; Tomas Vaisar; Alan T Remaley
Journal:  Lipids Health Dis       Date:  2020-08-21       Impact factor: 3.876

Review 9.  Apolipoprotein A-II, a Player in Multiple Processes and Diseases.

Authors:  Gabriela Florea; Irina Florina Tudorache; Elena Valeria Fuior; Radu Ionita; Madalina Dumitrescu; Ioana Madalina Fenyo; Violeta Georgeta Bivol; Anca Violeta Gafencu
Journal:  Biomedicines       Date:  2022-07-02

10.  Interactions of apolipoprotein A-I with high-density lipoprotein particles.

Authors:  David Nguyen; Margaret Nickel; Chiharu Mizuguchi; Hiroyuki Saito; Sissel Lund-Katz; Michael C Phillips
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.